Market cap
$50 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
7.7
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-3 Mln
-
ROE
-0.4 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
0
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
15,447,500
10 Years Aggregate
CFO
$-38.41 Mln
EBITDA
$-24.17 Mln
Net Profit
$-45.39 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
GlucoTrack Inc (GCTK)
| -30.3 | 1.2 | -17.0 | 754.5 | 157.6 | 8.3 | -- |
|
BSE Sensex*
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2021
|
2020
|
2019
|
2018
|
2016
|
2015
|
|---|---|---|---|---|---|---|
|
GlucoTrack Inc (GCTK)
| 1,074.6 | -40.3 | 20.0 | -75.0 | -28.6 | -41.7 |
|
S&P Small-Cap 600
| 25.3 | 9.6 | 20.9 | -9.7 | 24.7 | -3.4 |
|
BSE Sensex
| 22.0 | 15.8 | 14.4 | 5.9 | 1.9 | -5.0 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
GlucoTrack Inc (GCTK)
|
2.9 | 50.1 | 0.0 | -4.1 | -- | -57.5 | -- | 7.7 |
| 61.5 | 8,484.6 | 616.9 | -75.1 | 1.7 | -9.3 | -- | 10.1 | |
| 14.5 | 9,638.1 | 6,561.1 | -578.0 | -4.5 | -10.3 | -- | 1.7 | |
| 365.1 | 9,761.6 | 2,589.3 | 222.4 | -6.0 | 3 | 44.5 | 1.3 | |
| 57.5 | 9,074.5 | 3,499.6 | -71.2 | 0.5 | -3.2 | -- | 3.8 | |
| 180.0 | 10,905.5 | 612.8 | -188.1 | -30.6 | -28.1 | -- | 16.4 | |
| 100.5 | 6,525.3 | 1,556.3 | 275.3 | 24.6 | 22.9 | 24 | 5.0 | |
| 321.8 | 12,752.7 | 1,504.9 | 160.6 | 13.6 | 10.9 | 79.4 | 8.4 | |
| 178.2 | 10,222.2 | 785.1 | 41.5 | 9.9 | 2 | 251.6 | 4.8 | |
| 28.9 | 12,153.4 | 6,164.0 | 625.0 | 13.0 | 11.8 | 19.9 | 2.4 |
Shareholding Pattern
View DetailsAbout GlucoTrack Inc (GCTK)
GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Europe and the Asia Pacific. It develops GlucoTrack glucose... monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel. Read more
-
GM & VP of Product
Mr. Erez Ben-Zvi
-
GM & VP of Product
Mr. Erez Ben-Zvi
-
Headquarters
Or Yehuda
-
Website
FAQs for GlucoTrack Inc (GCTK)
What is the current share price of GlucoTrack Inc (GCTK) Today?
The share price of GlucoTrack Inc (GCTK) is $2.91 (NASDAQ) as of 13-May-2022 09:30 EDT. GlucoTrack Inc (GCTK) has given a return of 157.58% in the last 3 years.
What is the current PB & PE ratio of GlucoTrack Inc (GCTK)?
Since, TTM earnings of GlucoTrack Inc (GCTK) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2021 |
-- |
-- |
2020 |
-- |
-- |
2019 |
-- |
-- |
2018 |
-- |
-- |
2017 |
-- |
-- |
What is the 52 Week High and Low of GlucoTrack Inc (GCTK)?
The 52-week high and low of GlucoTrack Inc (GCTK) are Rs -- and Rs -- as of 30-Aug-2026.
What is the market cap of GlucoTrack Inc (GCTK)?
GlucoTrack Inc (GCTK) has a market capitalisation of $ 50 Mln as on 13-May-2022. As per SEBI classification, it is a Small Cap company.
Should I invest in GlucoTrack Inc (GCTK)?
Before investing in GlucoTrack Inc (GCTK), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.